Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Abstract Glucagon-like peptide-1 receptor agonist (GLP-1RA), a novel hypoglycemic agent for the treatment of type 2 diabetes, has well-known effects such as lowering blood sugar, ameliorating inflammation, reducing weight, and lowering blood lipids
Lanzinger S, Breitner S, Neas L, Cascio W, Diaz-Sanchez D, Hinderliter A, et al
GLP-1s do not usually cause hypoglycemia, unless combined with another agent/therapy that is associated with hypoglycemia such as sulfonylureas or insulin injections6,7
Mohammad Zamani 1, Naseh Pahlavani 2 3, Mahlagha Nikbaf-Shandiz 4, Niloufar Rasaei 5, Rasool Ghaffarian-Ensaf 6, Omid Asbaghi 7 8, Farideh Shiraseb 5, Samira Rastgoo The effects of L-carnitine supplementation on glycemic markers in adults: A systematic review and dose-response meta-analysis National Library of Medicine, 2023 Jan 10:9:1082097
